BioHealth News

IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol

IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol

-- Study Deepens Understanding of Treatments for Alzheimer’s Patients, Enabling More Effective Treatments -- POTOMAC, Md.--(June  10, 2024)--IGC Pharma, Inc. (NYSE American: IGC) (“IGC” or…

Read More
HyperSpectral Announces $8.5M Series A Funding to Accelerate Deployment of Spectral Artificial Intelligence Software

HyperSpectral Announces $8.5M Series A Funding to Accelerate Deployment of Spectral Artificial Intelligence Software

Company Focused on Bringing Industry-Leading Technology to Market in Food Safety and MedTech Industries  ALEXANDRIA, Va., June 5, 2024 /PRNewswire/ -- HyperSpectral, the world's first AI-powered spectral…

Read More
US FDA approves expanded age indication for GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk

US FDA approves expanded age indication for GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk

PHILADELPHIA, June 07, 2024--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved AREXVY (Respiratory Syncytial Virus…

Read More
Barinthus Bio’s VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B

Barinthus Bio’s VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B

OXFORD, United Kingdom, June 06, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), a biopharmaceutical company developing novel T cell immunotherapeutic candidates, today…

Read More
REPROCELL USA Receives Funding from Maryland Stem Cell Research Fund (MSCRF)

REPROCELL USA Receives Funding from Maryland Stem Cell Research Fund (MSCRF)

REPROCELL USA is proud to announce that it has received funding from MSCRF for both proposals it has submitted for the MSCRF's January 2024 grant cycle. These two…

Read More
I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers

I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers

ROCKVILLE, Md., June 5, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated…

Read More
JPMorgan Chase Furthers Commitment in Baltimore with Multimillion-Dollar Philanthropic Capital

JPMorgan Chase Furthers Commitment in Baltimore with Multimillion-Dollar Philanthropic Capital

The firm deepens its 130-year presence in Baltimore and commitment to driving inclusive economic growth; advances $20 million five-year philanthropic commitment to Baltimore  …

Read More
Montgomery County: A Life Sciences Hub According to Pete Briskman, Chair of BHI’s Board of Directors

Montgomery County: A Life Sciences Hub According to Pete Briskman, Chair of BHI’s Board of Directors

Montgomery County, Maryland, is a top destination for the life sciences industry. Pete Briskman, JLL’s Executive Managing Director and Chair of BioHealth Innovation Inc.'s…

Read More
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications

QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications

Venlo, the Netherlands, and Salt Lake City, Utah, May 30, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Myriad Genetics…

Read More
Alda Mizaku named chief data and artificial intelligence officer at Children’s National Hospital

Alda Mizaku named chief data and artificial intelligence officer at Children’s National Hospital

Washington, D.C., June 03, 2024 (GLOBE NEWSWIRE) -- Children’s National Hospital is pleased to welcome Alda Mizaku in a newly established role of vice…

Read More
AstraZeneca plans $1.5 billion manufacturing facility for antibody drug conjugates (ADCs) in Singapore

AstraZeneca plans $1.5 billion manufacturing facility for antibody drug conjugates (ADCs) in Singapore

AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its ADC portfolio. ADCs…

Read More
Innovators Wanted: Secure Federal Funding with BioHealth Innovation’s Help

Innovators Wanted: Secure Federal Funding with BioHealth Innovation’s Help

Did you know? Each year, the federal government dedicates around $3.6 billion towards SBIR and STTR programs, resulting in awards to over 5,000 innovative…

Read More
BioHealth Innovation Inc. Celebrates miRecule’s Triumph at INVEST Pitch Perfect

BioHealth Innovation Inc. Celebrates miRecule’s Triumph at INVEST Pitch Perfect

At BioHealth Innovation Inc. (BHI), we are happy to celebrate the achievements of our partner company, miRecule, which has recently been named a winner…

Read More
Advancing Biotech: Insights from Michael J. Tarlov, Chief of the Biomolecular Measurement Division at NIST on BioTalk

Advancing Biotech: Insights from Michael J. Tarlov, Chief of the Biomolecular Measurement Division at NIST on BioTalk

Join us for an enlightening episode of BioTalk with Rich Bendis, featuring Michael J. Tarlov, Chief of the Biomolecular Measurement Division at the Material…

Read More
New TEDCO Study Outlines Steps for Developing Maryland’s Cybersecurity Workforce

New TEDCO Study Outlines Steps for Developing Maryland’s Cybersecurity Workforce

COLUMBIA, Md., (May 29, 2024) — TEDCO, Maryland’s economic engine for technology companies, unveiled the recently completed “Cybersecurity Workforce Analysis and Study” (“Study”). The…

Read More